Skip to main content Skip to main navigation menu Skip to site footer

A case report: a 38-year-old man with vivax relapse malaria


Introduction: Malaria is a parasitic disease caused by blood protozoa of the Plasmodium genus transmitted through the bite of a female Anopheles mosquito. Indonesia is still an endemic area, especially in the eastern regions. About 40% of malaria cases in the world are caused by Plasmodium vivax. Tertiana or vivax malaria can cause relapse because it has a hypnozoite stage that is dormant in the liver. This case report will discuss a case of relapse vivax malaria with thrombocytopenia.

Case Illustration: A 38-year-old man came to the emergency room consciously with a fever complaint since 4 days before entering the hospital. Fever occurred throughout the body, disappeared, accompanied by chills and sweating. On the second day the fever began to decrease somewhat but the next day the fever began to increase. The patient has a history of serving in Papua and contracted malaria 3 months before entering the hospital. While in Papua, the patient worked as a supporter for the 2021 PON event and malaria treatment was not complete. A complete blood examination found thrombocytopenia and microscopic examination of thin drops of the presence of ring-shaped Plasmodium vivax. The patient is diagnosed with vivax relapse malaria. The patient was treated with antimalarial therapy with DHP 4 tablets in a day for 3 days and primaquine 2 tablets in a day for 14 days. Monitoring therapy was done on the eighth day, with microscopic examination, and the result was negative malaria plasmodium.

Conclusion: This case report discusses vivax relapse malaria and proper management to irradiate the hypnozoite stage which has an important role in the recurrence phase. 


  1. Salwati, Ervi, Reni Herman, Sarwo Handayani ET. Deteksi P. vivax Single Nucleotide Polymorphism (SNP) y976f dari Sampel Monitoring Pengobatan Dihidroartemisinin-piperakuin di Kalimantan dan Sulawesi. Media Litbang Kesehatan. 2012;22(3):112-119.
  2. WHO. World Malaria Report 2015. France; 2015.
  3. Kemenkes RI. Riskesdas 2013. Jakarta: Balitbangkes RI; 2013.
  4. Ronny A, Tjitra E. Artesunat-Amodiakuin dan Klorokuin untuk Pengobatan Malaria Vivaks di Puskesmas Kopeta, Maumere, Nusa Tenggara Timur, 2007. Media Litbangkes. 2014;24(4):161-168.
  5. Angulo I, Fresno M. Cytokines in the pathogenesis of and protection against malaria. Clinical and diagnostic laboratory immunology. 2002;9(6):1145-52.
  6. Andrade BB, Antonio RF, Sebastiao MS, Jorge C, Luis MA, Aldina B, et al. Severe Plasmodium vivax malaria exhibits marked inflammatory imbalance. Malaria journal [internet]. 2010 [diakses tanggal 16 Juni 2022];9(13):1-8. Tersedia dari: /articles/10.1186/1475-2875-9-13
  7. Abadalla, S. dan Pasvol, G. 2004, A hematological Perspective. Imperial College Press, London.
  8. Ottay RI. Profil Penyakit Malaria Pada Penderita Rawat Inap Di Rumah Sakit Umum Daerah Kota Bitung. J Biomedik. 2011;3:172-178.
  9. CDC. 2013. Malaria: Scheme of The Life Cycle. Diunduh dari: [Diakses Juni 2022]
  10. Gonzalez, R.C. and Woods, R.E. (2008) Digital Image Processing. 3rd Edition, Pearson Prentice Hall, Upper Saddle River.
  11. WHO, 2015. World Malaria Report 2015. [pdf] Geneva: World Health Organization. Tersedia di: publications/world-malaria-report-2015/ report/en/
  12. Crutcher JM, Hoffman SL. Malaria. In: Baron S, editor. Medical Microbiology. 4th edition. Galveston (TX): University of Texas Medical Branch at Galveston; 1996. Chapter 83
  13. Dini S, Douglas NM, Poespoprodjo JR, Kenangalem E, Sugiarto P, Plumb ID, et al. The risk of morbidity and mortality following recurrent malaria in Papua , Indonesia : a retrospective cohort study. BMC Med. 2020;18(28):1–12.
  14. Li Z, Zhang Q, Zheng C, Zhou S, Sun J, Zhang Z, et al. Epidemiologic features of overseas imported malaria in the People ’ s Republic of China. Malar J. 2016;15(1):1–9.
  15. Depkes RI. Buku saku penatalaksanaan kasus malaria di Indonesia. Jakarta: Ditjen Pencegahan dan Pengendalian Penyakit Kementerian Kesehatan RI; 2020.
  16. Kusuma W, Lestari AAW, Herawati S, Yasa IWPS. Pemeriksaan Mikroskop dan Tes Diagnostik Cepat dalam Menegakkan Diagnosis Malaria. E-Journal Med Udayana. 2006;3(2):1–16.
  17. Utami BS, Estiana L, Tuti S. Penggunaan Rapid Diagnostik Test (RDT) oleh kader sebagai alat bantu dalam penemuan kasus malaria di Desa Guntur, Kecamatan Bener, Kabupaten Purworejo. Jurnal Ekologi Kesehatan 2008: 740-746
  18. Hasugian AR, Wibowo H, Tjitra E. Hubungan Trombositopenia , Parasitemia serta Mediator Pro dan Anti Inflamasi pada Infeksi Malaria , Timika 2010. Media Litbangkes. 2018;28(3):183–90
  19. Price RN, Commons RJ, Battle KE, Thriemer K, Mendis K. Plasmodium vivax in the Era of the Shrinking P . falciparum Map. Trends Parasitol [Internet]. 2020;36(6):560–70. Available from:
  20. Chaves YO, Guimarães A, Luís M, Pereira M, Vinícius M, Lacerda G De, et al. Immune response pattern in recurrent Plasmodium vivax malaria. Malar J. 2016;15(1):1–13.
  21. Poespoprodjo JR, Kenangalem E, Wafom J, et al. Therapeutic Response to Dihydroartemisinin-Piperaquine for P. falciparum and P. vivax Nine Years after Its Introduction in Southern Papua, Indonesia. Am J Trop Med Hyg. 2018;98(3):677-682. doi:10.4269/ajtmh.17-0662
  22. Lacerda MV, Mourão MP, Coelho HC, Santos JB. Thrombocytopenia in malaria: who cares?. Mem Inst Oswaldo Cruz. 2011;106 Suppl 1:52-63. doi:10.1590/s0074-02762011000900007

How to Cite

Paramitha, A. A. P. ., Darmawan, I. P. G. P., & Fitriani, R. A. . (2022). A case report: a 38-year-old man with vivax relapse malaria. Intisari Sains Medis, 13(3), 602–607.




Search Panel

Ayu Agung Pradnya Paramitha
Google Scholar
ISM Journal

I Putu Gede Putra Darmawan
Google Scholar
ISM Journal

Rachmawanti Agustina Fitriani
Google Scholar
ISM Journal